Access to some NICE approved drugs varies hugely across England

被引：1
|
作者：
Torjesen, Ingrid
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 348卷
关键词：
D O I：
10.1136/bmj.g465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Prescribing cannabis based drugs: response from NICE and Health Education England
    Spring, Marion
    Bingham, Helen
    Bryant, Sue Lacey
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [32] THE NICE CRUNCH? CAPACITY CONSTRAINTS LEADING TO POTENTIAL INCONSISTENCIES IN THE ASSESSMENT OF DRUGS IN ENGLAND
    Macaulay, R.
    Gray, P.
    Griffiths, E. A.
    VALUE IN HEALTH, 2017, 20 (05) : A66 - A66
  • [33] Some implications of off-label use of approved drugs
    Reinhold, P
    Usselmann, B
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 1999, 40 (10): : 701 - 708
  • [34] PATIENT ACCESS TO HEMOPHILIA A TREATMENT VARIES ACROSS US COMMERCIAL HEALTH PLANS
    Margaretos, N.
    Patel, A. M.
    Panzer, A. D.
    Khairnar, R.
    Chambers, J.
    VALUE IN HEALTH, 2020, 23 : S338 - S338
  • [35] NICE lifts cost limit on drugs to improve access to end of life treatments
    Kmietowicz, Zosia
    BRITISH MEDICAL JOURNAL, 2009, 338
  • [36] Patients' Access to 2018 FDA-Approved Drugs 1 Year Post
    Panzer, Ari D.
    Margaretos, Nikoletta M.
    Bridger, Naomi
    Osani, Mikala C.
    Lai, Rachel C.
    Chambers, James D.
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (04): : E153 - E156
  • [37] Access to orphan drugs - comparison across Balkan countries
    Pejcic, Ana V.
    Iskrov, Georgi
    Jakovljevic, Mihajlo Michael
    Stefanov, Rumen
    HEALTH POLICY, 2018, 122 (06) : 583 - 589
  • [38] New HIV drugs approved after some deal-making
    Cimons, M
    NATURE MEDICINE, 1996, 2 (04) : 376 - 377
  • [39] Patients’ access to rare neuromuscular disease therapies varies across US private insurers
    Nikoletta M. Margaretos
    Komal Bawa
    Natalie J. Engmann
    James D. Chambers
    Orphanet Journal of Rare Diseases, 17
  • [40] Patients' access to rare neuromuscular disease therapies varies across US private insurers
    Margaretos, Nikoletta M.
    Bawa, Komal
    Engmann, Natalie J.
    Chambers, James D.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
12345